BDRA Plain Language Summary Xu et al. 2021.pdf (269.78 kB)
Download file

Efficacy, safety and immunogenicity of HLX02 compared with reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a randomized phase 3 equivalence trial

Download (269.78 kB)
media
posted on 16.03.2021, 09:02 by Binghe Xu, Qingyuan Zhang, Tao Sun, Wei Li, Yue’e Teng, Xichun Hu, Igor Bondarenko, Hryhoriy Adamchuk, Liangming Zhang, Dmytro Trukhin, Shusen Wang, Hong Zheng, Zhongsheng Tong, Yaroslav Shparyk, Qingyu Wang

Article full text


https://doi.org/10.1007/s40259-021-00475-w


The above Plain Language Summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History